You are currently viewing Rep. Cori Bush’s Controversial Abortion Pill Statement Sparks Debate

Rep. Cori Bush’s Controversial Abortion Pill Statement Sparks Debate

Protect Your Finances With A Gold IRA

Noble Gold is Who I Trust ^^^

Democratic Representative Cori Bush has stirred controversy by comparing the abortion pill, mifepristone, to common headache medication like Tylenol. This statement has sparked outrage among pro-life advocates, who highlight the pill’s role in ending the lives of unborn children. The controversy comes as pro-life laws gain traction in several states, with Iowa Governor Kim Reynolds recently signing a heartbeat bill. A Texas law similar to this has reportedly resulted in nearly 10,000 more births in the past year. Despite these pro-life victories, Bush continues to defend mifepristone, calling it a ‘lifeline’ for women. Critics argue that the real lifeline should be extended to the unborn.

View the full report here:

Read More:

Check out our Link Tree:

Sub to the channel:

Get On Our Email List:

Donate With Paypal:
Give BTC: 13Hd1HFqS5CDLCMcFQPWu9wumubo6X2hSM
Next News T-Shirt Shop:

Books That Teach Freedom!

Get the equivalent of a Ph.D. in libertarian thought and
free-market economics online for just 24 cents a day!

Restore YOUR Online Privacy here:
Enter Promo Code: nextnews for 20% OFF !

Be Ready in ANY disaster. Stock up on Survival Food here:


Copyright Disclaimer: Citation of articles and authors in this report does not imply ownership. Works and images presented here fall under Fair Use Section 107 and are used for commentary on globally significant newsworthy events. Under Section 107 of the Copyright Act 1976, allowance is made for fair use for purposes such as criticism, comment, news reporting, teaching, scholarship, and research.

Community Guidelines Disclaimer: The points of view and purpose of this video is not to bully or harass anybody, but rather share that opinion and thoughts with other like-minded individuals curious about the subject.

#NextNews #core

Leave a Reply